Wednesday, May 25, 2016

BRIEF-Txcell obtains authorization to restart Ovasave phase IIb clinical trial

* Obtains authorization from European regulatory authorities

to restart Ovasave phase IIb clinical trial

Source text for Eikon:

Further company coverage:

(Gdynia Newsroom)

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)